NASDAQ: OPCH · Medical Care Facilities

Option Care Health (OPCH) fair value: undervalued or overvalued?

As of 14 Nov 2026, Faircurve's model values Option Care Health (OPCH) at $32.92 a share. The stock last closed at $31.71, which puts the model's fair value 3.8% above the price. On the model's bands that reads as Fairly valued.

Revalued . Price is the close of 16 Nov 2026. Option Care Health, Inc.

The report adds the live price, the price chart, the next earnings date and the analysts' consensus. No account needed.

Model fair value$32.92midpoint of 2,000 simulations
Last close$31.71NASDAQ: OPCH
Gap to fair value+3.8%fair value against price
Model verdictFairly valuedevidence grade: Medium

This week, in three parts

What happenedThe run of 14 Nov 2026 held the fair value at $32.92, within 1% of the run of 7 Nov 2026.

What the model makes of itThe price of $31.71 is 3.8% below it: Fairly valued, on a medium evidence grade.

What's nextNext report on 23 Feb 2027. The next weekly run is on Saturday 21 Nov 2026.

What price range does the model give OPCH?

The calibrated range for OPCH over 63 trading days is $26.33 to $39.11. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 13,250 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon.

The model's own simulated range, from the 20th to the 80th percentile of its runs, is $23.88 to $44.44. In 54% of the simulations the fair value came out above the price the model ran on.

$15.20$66.13
Spread of the 2,000 simulated fair values. Solid line: the midpoint, $32.92. Dashed line: the last close, $31.71.

Faircurve Insights · 14 Nov 2026

Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. It is classed under Healthcare, Medical Care Facilities.

Faircurve's model put the fair value of Option Care Health at $32.92 a share on 14 Nov 2026, the midpoint of 2,000 simulations. The previous run, on 7 Nov 2026, gave $32.97, so the fair value moved -0.2%. The calibrated range over 63 trading days is $26.33 to $39.11. It is built from the fair value, as there is no live options data for the stock. Calibrated weekly against 13,250 past valuations, such ranges held the price 60% of the time at this horizon. The evidence grade is Medium. It reflects input completeness, the number of comparable companies and how closely they agree, and the spread of outcomes. It does not say whether the fair value is right.

The model gives Option Care Health an overall quality score of 62 out of 100, a composite of six factors scored against comparable companies. Stability scores 100, with five-year EBITDA margin downside volatility of 0.7 pts against a peer median of 1.1 pts. Earnings quality and capital discipline each score 88: FCF to net income is 1.29x against a peer median of 0.83x, and net buybacks are 5.6% of market value against a peer median of 0.6%. The peer set includes Hims & Hers Health, Concentra, Chemed, Universal Health Services and Addus HomeCare.

Written from the figures on this page for the 14 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.

The Global Pulse

Faircurve's note after each US session, in your inbox. No account needed.

When does OPCH report earnings, and how has the stock reacted?

Option Care Health's next earnings report is scheduled for 23 Feb 2027. Companies can move their dates.

Around its last 8 reports: what the options market priced, and what followed

Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across OPCH's last 8 reports, ignoring direction, was 2.2%.

0%10%20%30%11.6%1.7%26 Feb '25no quote2.6%30 Jul '2512.6%9.2%30 Oct '2510.1%6.9%24 Feb '2617.4%25.5%30 Apr '2618.3%0.1%29 Jul '26no quote1.7%29 Oct '26no quote0.8%4 Nov '26priced before the reportthe move that followed
What the options market priced for each report, against the size of the move that followed. Priced: the move implied by options expiring after the report, on the last quote before it. Followed: the close before the report to the close after. Sizes only, no direction.

How does OPCH score on business quality?

Option Care Health's overall quality score is 62 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.

FactorScore (0 to 100)Headline measurePeer median
ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend.4010.9%ROIC15.9%
Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash).881.29xFCF / net income0.83x
Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes.4213.0%Revenue growth, trailing15.3%
Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks.885.6%Net buybacks / market value0.6%
Balance sheetNet debt to EBITDA and interest coverage.472.27xNet debt / EBITDA3.30x
StabilityDownside volatility of the EBITDA margin over the last five years.1000.7 ptsEBITDA margin downside volatility, 5y1.1 pts

How does OPCH compare with similar companies?

The companies in medical care facilities closest to Option Care Health in market value, each on the same model and the same date.

CompanyLast closeModel fair valueGapModel verdict
HIMS Hims & Hers Health, Inc.$18.56$21.46+15.6%Undervalued
CON Concentra Group Holdings Parent, Inc.$43.44$43.92+1.1%Fairly valued
ACHC Acadia Healthcare Company, Inc.$38.70$44.44+14.8%Low evidence grade
NHC National HealthCare Corporation$207.19$249.00+20.2%Low evidence grade
CHE Chemed Corporation$549.45$568.98+3.6%Fairly valued
MD Pediatrix Medical Group, Inc.$31.89$35.38+10.9%Low evidence grade
UHS Universal Health Services, Inc.$197.80$310.03+56.7%Undervalued
ADUS Addus HomeCare Corporation$124.61$133.49+7.1%Fairly valued

What the comparable companies' multiples alone would give for OPCH, the peer-implied price, is $39.58 a share on this run. The fair value weighs that against the company's own multiple.

All medical care facilities stocks ranked by gap to fair value

Option Care Health at a glance

Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States.

Market value
$4.7B
Sector
Healthcare
Industry
Medical Care Facilities
Revenue expected, next twelve months
$6.1B
Consensus revenue growth, next fiscal year
+2.2%
Analysts with estimates
6
Beta to the US market
-0.09
First valued by Faircurve
11 Jul 2026

At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. OPCH was among them.

How the fair value is worked out: the model prices Option Care Health on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.

What changed in the latest valuation?

On 7 Nov 2026 the model's fair value for OPCH was $32.97. As of 14 Nov 2026 it is $32.92, a change of -0.2%. The model revalues every stock it covers each week, and again after an earnings report.

Questions about Option Care Health's valuation

Is Option Care Health stock undervalued or overvalued?

On Faircurve's model, OPCH reads as Fairly valued as of 14 Nov 2026. The model's fair value is $32.92 a share against a last close of $31.71, a gap of +3.8%.

What is OPCH's fair value?

$32.92 a share as of 14 Nov 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $23.88 to $44.44.

What price range does the model give OPCH?

$26.33 to $39.11 over 63 trading days. Ranges built this way held the price 60% of the time across 13,250 past valuations, refreshed 14 Nov 2026.

When does Option Care Health report earnings next?

The next report is scheduled for 23 Feb 2027. Companies can move their dates.

How much has OPCH moved on past earnings reports?

Across its last 8 reports the median two session move was 2.2%, ignoring direction. The largest was -25.5% around the report of 30 Apr 2026.

How confident is the model in this valuation?

The model's evidence grade for OPCH is medium. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.

The model's own ideas on OPCH

The model holds no idea open on OPCH today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on OPCH with their outcomes. A free account is enough.

Keep reading